A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men. - Sakamoto, Kei; Matsuki, Shunji; Irie, Shin; Uchida, Naoki; Hayashi, Nobuya; Horiuchi, Masato; Ren, Song (Clinical Pharmacology in Drug Development, 2020)